Authorization

Vasyl Khmelnytsky told about the new plant on the basis of “Biopharma”

Vasyl Khmelnytsky told about the new plant on the basis of “Biopharma”

The Chronicle India
According to him, a complex of this kind is the only one in the CIS. $ 42 million was invested in the construction. There is a pharmaceutical plant, a centre of research, development, and technology, a laboratory, raw material stores and finished product storages and a power-supply system site in the territory of 5 hectares.
The German partners from the engineering company “Linde Engineering” helped to design the “Biopharma” plant. The complex itself was built at a record pace – within a year and three months.
In the nearest time, construction of the third stage of the research and production complex – a blood plasma plant – should be completed. It will produce drugs for the treatment of immunodeficiency diseases – immunoglobulin, albumin, bioven.
At the moment, “Biopharma” has become a top performer in the domestic market of Ukraine and is developing new markets – in particular, in Asia, Africa and the Middle East. Recently, the delegation of “Biopharma” has visited the countries of South America – Argentina, Chile, Ecuador, Peru and Bolivia.
“The Latin American market is very promising. It is developing rapidly, and it is necessary to establish cooperation with it,” Vasyl Khmelnytsky said.
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Август 2018    »
ПнВтСрЧтПтСбВс
 12345
6789101112
13141516171819
20212223242526
2728293031